Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Nuclear Medicine

  Free Subscription

Articles published in Ann Nucl Med

Retrieve available abstracts of 150 articles:
HTML format

Single Articles

    October 2022
  1. TSUKADA H, Tsukada J, Ochi T, Noguchi E, et al
    Radiological predictive factors on preoperative multimodality imaging are related to Oncotype DX recurrence score in estrogen-positive/human epidermal growth factor receptor 2-negative invasive breast cancer: a cross-sectional study.
    Ann Nucl Med. 2022;36:853-864.
    PubMed     Abstract available

    September 2022
  2. LIU J, Yu J, Liu HB, Yao Q, et al
    Chronic fluoxetine enhances extinction therapy for PTSD by evaluating brain glucose metabolism in rats: an [(18)F]FDG PET study.
    Ann Nucl Med. 2022 Sep 30. pii: 10.1007/s12149-022-01790.
    PubMed     Abstract available

  3. MIZUTA T, Yamakawa Y, Minagawa S, Kobayashi T, et al
    Attenuation correction for phantom tests: an alternative to maximum-likelihood attenuation correction factor-based correction for clinical studies in time-of-flight PET.
    Ann Nucl Med. 2022 Sep 28. pii: 10.1007/s12149-022-01788.
    PubMed     Abstract available

  4. WATANABE M, Kato H, Katayama D, Soeda F, et al
    Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose-positron emission tomography to differentiate between benign and malignant lesions.
    Ann Nucl Med. 2022 Sep 3. pii: 10.1007/s12149-022-01784.
    PubMed     Abstract available

  5. ICHIKAWA H, Shibutani T, Onoguchi M, Taniguchi Y, et al
    New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT.
    Ann Nucl Med. 2022 Sep 1. pii: 10.1007/s12149-022-01783.
    PubMed     Abstract available

    August 2022
  6. TELLI TA, Ozguven S, Alan O, Filizoglu N, et al
    Role of baseline (68)Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment.
    Ann Nucl Med. 2022 Aug 23. pii: 10.1007/s12149-022-01785.
    PubMed     Abstract available

  7. NAKAJIMA K, Saito S, Chen Z, Komatsu J, et al
    Diagnosis of Parkinson syndrome and Lewy-body disease using (123)I-ioflupane images and a model with image features based on machine learning.
    Ann Nucl Med. 2022;36:765-776.
    PubMed     Abstract available

  8. UKON N, Higashi T, Hosono M, Kinuya S, et al
    Manual on the proper use of meta-[(211)At] astato-benzylguanidine ([(211)At] MABG) injections in clinical trials for targeted alpha therapy (1st edition).
    Ann Nucl Med. 2022;36:695-709.
    PubMed     Abstract available

  9. SAKURAI K, Nihashi T, Kimura Y, Iwata K, et al
    Age-related increase of monoamine oxidase B in amyloid-negative cognitively unimpaired elderly subjects.
    Ann Nucl Med. 2022;36:777-784.
    PubMed     Abstract available

  10. KOMORI S, Cross DJ, Mills M, Ouchi Y, et al
    Deep-learning prediction of amyloid deposition from early-phase amyloid positron emission tomography imaging.
    Ann Nucl Med. 2022 Aug 1. pii: 10.1007/s12149-022-01775.
    PubMed     Abstract available

    July 2022
  11. NAKAMOTO Y, Kitajima K, Toriihara A, Nakajo M, et al
    Recent topics of the clinical utility of PET/MRI in oncology and neuroscience.
    Ann Nucl Med. 2022 Jul 27. pii: 10.1007/s12149-022-01780.
    PubMed     Abstract available

  12. LV J, Yin H, Yu H, Liu G, et al
    The feasibility of ultralow-activity (18)F-FDG dynamic PET imaging in lung adenocarcinoma patients through total-body PET/CT scanner.
    Ann Nucl Med. 2022 Jul 20. pii: 10.1007/s12149-022-01772.
    PubMed     Abstract available

  13. IWAO Y, Akamatsu G, Tashima H, Takahashi M, et al
    Brain PET motion correction using 3D face-shape model: the first clinical study.
    Ann Nucl Med. 2022 Jul 19. pii: 10.1007/s12149-022-01774.
    PubMed     Abstract available

  14. GIHBID A, Cherkaoui Salhi G, El Alami I, Belgadir H, et al
    Pretreatment [(18)F]FDG PET/CT and MRI in the prognosis of nasopharyngeal carcinoma.
    Ann Nucl Med. 2022 Jul 14. pii: 10.1007/s12149-022-01770.
    PubMed     Abstract available

  15. YANG W, Zhong Z, Feng G, Wang Z, et al
    Advances in positron emission tomography tracers related to vascular calcification.
    Ann Nucl Med. 2022 Jul 14. pii: 10.1007/s12149-022-01771.
    PubMed     Abstract available

  16. NISHIMORI M, Iwasa H, Miyatake K, Nitta N, et al
    18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma.
    Ann Nucl Med. 2022 Jul 12. pii: 10.1007/s12149-022-01773.
    PubMed     Abstract available

  17. IMABAYASHI E, Tamamura N, Yamaguchi Y, Kamitaka Y, et al
    Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
    Ann Nucl Med. 2022 Jul 11. pii: 10.1007/s12149-022-01769.
    PubMed     Abstract available

  18. CUI B, Shan Y, Zhang T, Ma Y, et al
    Crossed cerebellar diaschisis-related supratentorial hemodynamic and metabolic status measured by PET/MR in assessing postoperative prognosis in chronic ischemic cerebrovascular disease patients with bypass surgery.
    Ann Nucl Med. 2022 Jul 5. pii: 10.1007/s12149-022-01766.
    PubMed     Abstract available

  19. KUNITA Y, Nakajima K, Nakata T, Kudo T, et al
    Prediction of multivessel coronary artery disease and candidates for stress-only imaging using multivariable models with myocardial perfusion imaging.
    Ann Nucl Med. 2022;36:674-683.
    PubMed     Abstract available

  20. NDLOVU H, Lawal IO, Popoola GO, Brits B, et al
    [(68)Ga]Ga-NODAGAZOL uptake in atherosclerotic plaques correlates with the cardiovascular risk profile of patients.
    Ann Nucl Med. 2022;36:684-692.
    PubMed     Abstract available

  21. YILMAZ B, Sahin S, Ergul N, Colakoglu Y, et al
    (99m)Tc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients.
    Ann Nucl Med. 2022;36:597-609.
    PubMed     Abstract available

    June 2022
  22. PAPANDRIANOS NI, Apostolopoulos ID, Feleki A, Apostolopoulos DJ, et al
    Deep learning exploration for SPECT MPI polar map images classification in coronary artery disease.
    Ann Nucl Med. 2022 Jun 30. pii: 10.1007/s12149-022-01762.
    PubMed     Abstract available

  23. FARKAS B, Kepes Z, Barna SK, Szugyiczki V, et al
    Unusual perfusion patterns on perfusion-only SPECT/CT scans in COVID-19 patients.
    Ann Nucl Med. 2022 Jun 28. pii: 10.1007/s12149-022-01761.
    PubMed     Abstract available

  24. LI J, Huang L, Luo Y, Zhang K, et al
    Inferences of SPECT renal dynamic imaging injection quality based on lung and abdominal aorta imaging features.
    Ann Nucl Med. 2022 Jun 22. pii: 10.1007/s12149-022-01750.
    PubMed     Abstract available

  25. DE JONG TL, Koopman D, van Dalen JA, Tegelaar A, et al
    Performance of digital PET/CT compared with conventional PET/CT in oncologic patients: a prospective comparison study.
    Ann Nucl Med. 2022 Jun 21. pii: 10.1007/s12149-022-01758.
    PubMed     Abstract available

  26. ONISHI Y, Isobe T, Ito M, Hashimoto F, et al
    Performance evaluation of dedicated brain PET scanner with motion correction system.
    Ann Nucl Med. 2022 Jun 13. pii: 10.1007/s12149-022-01757.
    PubMed     Abstract available

  27. XU J, Li Y, Xie L, Sun X, et al
    An evaluation of the response to neoadjuvant chemotherapy for osteosarcoma of extremities: PERCIST versus RECIST 1.1 criteria after long-term follow-up.
    Ann Nucl Med. 2022;36:553-561.
    PubMed     Abstract available

    May 2022
  28. APRIL G, De Bruycker JJ, Decaluwe H, Haddad E, et al
    Evaluation of physiological Waldeyer's ring, mediastinal blood pool, thymic, bone marrow, splenic and hepatic activity with (18)F-FDG PET/CT: exploration of normal range among pediatric patients.
    Ann Nucl Med. 2022 May 29. pii: 10.1007/s12149-022-01748.
    PubMed     Abstract available

  29. TOMITA Y, Ichikawa Y, Sakuma H
    Shine-through artifact due to high-radioactivity bladder and bowel gas in (18)F-FDG PET/CT: impact of time-of-flight algorithm and radioactivity concentration of urine in the bladder on the occurrence of the artifacts.
    Ann Nucl Med. 2022 May 28. pii: 10.1007/s12149-022-01756.
    PubMed     Abstract available

  30. IBARAKI M, Matsubara K, Shinohara Y, Shidahara M, et al
    Brain partial volume correction with point spreading function reconstruction in high-resolution digital PET: comparison with an MR-based method in FDG imaging.
    Ann Nucl Med. 2022 May 26. pii: 10.1007/s12149-022-01753.
    PubMed     Abstract available

  31. SHIMIZU Y, Satake H, Ishigaki S, Shimamoto K, et al
    Physiological background parenchymal uptake of (18)F-FDG in normal breast tissues using dedicated breast PET: correlation with mammographic breast composition, menopausal status, and menstrual cycle.
    Ann Nucl Med. 2022 May 24. pii: 10.1007/s12149-022-01754.
    PubMed     Abstract available

  32. BAI Z, Zhou T, Yu Z, Chen Y, et al
    Clinical value of (18)F-FDG PET/CT in IgG4-related disease.
    Ann Nucl Med. 2022 May 23. pii: 10.1007/s12149-022-01749.
    PubMed     Abstract available

  33. CHEN Y, Zheng S, Zhang J, Yao S, et al
    (68)Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients.
    Ann Nucl Med. 2022 May 12. pii: 10.1007/s12149-022-01742.
    PubMed     Abstract available

  34. FUKAI S, Daisaki H, Umeda T, Shimada N, et al
    Impact of patient body habitus on image quality and quantitative value in bone SPECT/CT.
    Ann Nucl Med. 2022 May 11. pii: 10.1007/s12149-022-01746.
    PubMed     Abstract available

  35. TAN X, Li D, Wu X, Yang Y, et al
    Physiologically intense FDG uptake of distal spinal cord on total-body PET/CT.
    Ann Nucl Med. 2022 May 10. pii: 10.1007/s12149-022-01747.
    PubMed     Abstract available

  36. BECK M, Hartwich J, Eckstein M, Schmidt D, et al
    F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial.
    Ann Nucl Med. 2022 May 10. pii: 10.1007/s12149-022-01744.
    PubMed     Abstract available

  37. TALEBI AS, Rajabi H, Watabe H
    Role of nanoparticles in transarterial radioembolization with glass microspheres.
    Ann Nucl Med. 2022;36:479-487.
    PubMed     Abstract available

  38. YOSHIDA A, Ueda D, Higashiyama S, Katayama Y, et al
    Deep learning-based detection of parathyroid adenoma by (99m)Tc-MIBI scintigraphy in patients with primary hyperparathyroidism.
    Ann Nucl Med. 2022;36:468-478.
    PubMed     Abstract available

  39. SHIGEMOTO Y, Matsuda H, Kimura Y, Chiba E, et al
    Voxel-based analysis of age and gender effects on striatal [(123)I] FP-CIT binding in healthy Japanese adults.
    Ann Nucl Med. 2022;36:460-467.
    PubMed     Abstract available

    April 2022
  40. YAMA N, Nagoya S, Sugita S, Koyama M, et al
    Diagnosis of prosthetic joint infection at the hip using the standard uptake value of three-phase 99mTc-hydroxymethylene diphosphonate SPECT/CT.
    Ann Nucl Med. 2022 Apr 28. pii: 10.1007/s12149-022-01745.
    PubMed     Abstract available

  41. ERDOGAN M, Sengul SS, Cetin B, Avci M, et al
    The role of Ga(68) PSMA PET/CT imaging in Lu(177) PSMA treatment planning in metastatic castration-resistant prostate cancer.
    Ann Nucl Med. 2022 Apr 9. pii: 10.1007/s12149-022-01739.
    PubMed     Abstract available

  42. KIM D, Lee WJ, Lee HW, Kim BS, et al
    Application of (18)F-FDG brain PET for survival prediction in a rat model of hanging-induced hypoxic brain injury.
    Ann Nucl Med. 2022 Apr 5. pii: 10.1007/s12149-022-01738.
    PubMed     Abstract available

  43. OKUDA K, Saito H, Yamashita S, Yamamoto H, et al
    Beads phantom for evaluating heterogeneity of SUV on (18)F-FDG PET images.
    Ann Nucl Med. 2022 Apr 4. pii: 10.1007/s12149-022-01740.
    PubMed     Abstract available

  44. ZOU S, Song S, Zhou J, Yu B, et al
    Time point-independent tumor positivity of (68)Ga-PSMA-PET/CT pre- and post-biopsy in high-risk prostate cancer.
    Ann Nucl Med. 2022 Apr 1. pii: 10.1007/s12149-022-01732.
    PubMed     Abstract available

  45. KUBOTA K, Saginoya T, Ishiwata K, Nakasato T, et al
    [(18)F]FDG uptake in axillary lymph nodes and deltoid muscle after COVID-19 mRNA vaccination: a cohort study to determine incidence and contributing factors using a multivariate analysis.
    Ann Nucl Med. 2022;36:340-350.
    PubMed     Abstract available

  46. NAKATA T, Shimada K, Iba A, Oda H, et al
    Correlation between noise pareidolia test scores for visual hallucinations and regional cerebral blood flow in dementia with Lewy bodies.
    Ann Nucl Med. 2022;36:384-392.
    PubMed     Abstract available

  47. BAUCKNEHT M, Lai R, D'Amico F, Miceli A, et al
    Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223.
    Ann Nucl Med. 2022;36:373-383.
    PubMed     Abstract available

  48. KIDERA E, Koyasu S, Hayakawa N, Ishimori T, et al
    Association between diffuse renal uptake of (18)F-FDG and acute kidney injury.
    Ann Nucl Med. 2022;36:351-359.
    PubMed     Abstract available

    March 2022
  49. FISCHER M, Weinberger T, Messerer D, Zacherl MJ, et al
    Comparison of transient and permanent LAD ligation in mice using 18F-FDG PET imaging.
    Ann Nucl Med. 2022 Mar 30. pii: 10.1007/s12149-022-01734.
    PubMed     Abstract available

  50. SUZUKI M, Izawa Y, Fujita H, Miwa K, et al
    Efficacy of myocardial washout of (99m)Tc-MIBI/Tetrofosmin for the evaluation of inflammation in patients with cardiac sarcoidosis: comparison with (18)F-fluorodeoxyglucose positron emission tomography findings.
    Ann Nucl Med. 2022 Mar 18. pii: 10.1007/s12149-022-01735.
    PubMed     Abstract available

  51. OTANI T, Saga T, Ishimori T, Kidera E, et al
    Correction to: Detection efficacy of PET/CT with (18)F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study.
    Ann Nucl Med. 2022 Mar 17. pii: 10.1007/s12149-022-01736.

  52. KRENGLI M, Ferrara E, Guaschino R, Puta E, et al
    18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment.
    Ann Nucl Med. 2022 Mar 11. pii: 10.1007/s12149-022-01733.
    PubMed     Abstract available

  53. EUDE F, Guisier F, Salaun M, Thiberville L, et al
    Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab.
    Ann Nucl Med. 2022;36:224-234.
    PubMed     Abstract available

  54. MIYAZAKI Y, Kameyama M, Nakamizo A, Noguchi T, et al
    Validity of the gamma-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test.
    Ann Nucl Med. 2022;36:279-284.
    PubMed     Abstract available

  55. TAKAHASHI M, Yoshimura S, Takyu S, Aikou S, et al
    A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from LNs data of 20 esophageal cancer patients.
    Ann Nucl Med. 2022;36:285-292.
    PubMed     Abstract available

  56. MORISHIMA M, Kiriyama T, Miyagi Y, Otsuka T, et al
    Serial change in perfusion-metabolism mismatch after coronary artery bypass grafting.
    Ann Nucl Med. 2022;36:244-254.
    PubMed     Abstract available

  57. LUE KH, Chu SC, Wang LY, Chen YC, et al
    Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma.
    Ann Nucl Med. 2022;36:256-266.
    PubMed     Abstract available

    February 2022
  58. AHMED N, Sadeq A, Marafi F, Gnanasegaran G, et al
    Therapy-induced bone changes in oncology imaging with (18)F-sodium fluoride (NaF) PET-CT.
    Ann Nucl Med. 2022 Feb 26. pii: 10.1007/s12149-022-01730.
    PubMed     Abstract available

  59. NESTEROV SV, Deshayes E, Juarez-Orozco LE, deKemp RA, et al
    Myocardial perfusion quantification with Rb-82 PET: good interobserver agreement of Carimas software on global, regional, and segmental levels.
    Ann Nucl Med. 2022 Feb 22. pii: 10.1007/s12149-022-01729.
    PubMed     Abstract available

  60. WANG L, Han X, Wang M, Ma X, et al
    Ventilation/perfusion imaging predicts response to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
    Ann Nucl Med. 2022 Feb 22. pii: 10.1007/s12149-022-01731.
    PubMed     Abstract available

  61. CHO SG, Kim YH, Park H, Park KS, et al
    Prediction of cardiac events following concurrent chemoradiation therapy for non-small-cell lung cancer using FDG PET.
    Ann Nucl Med. 2022 Feb 17. pii: 10.1007/s12149-022-01724.
    PubMed     Abstract available

  62. MIZUTA T, Kobayashi T, Yamakawa Y, Hanaoka K, et al
    Initial evaluation of a new maximum-likelihood attenuation correction factor-based attenuation correction for time-of-flight brain PET.
    Ann Nucl Med. 2022 Feb 9. pii: 10.1007/s12149-022-01721.
    PubMed     Abstract available

  63. ZHAO L, Wang H, Shi J
    (18)F-FDG PET/CT characteristics of solitary fibrous tumour of the pleura: single institution experience.
    Ann Nucl Med. 2022 Feb 8. pii: 10.1007/s12149-022-01723.
    PubMed     Abstract available

  64. PLYKU D, Hobbs RF, Wu D, Garcia C, et al
    I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response.
    Ann Nucl Med. 2022 Feb 4. pii: 10.1007/s12149-021-01655.
    PubMed     Abstract available

  65. NAGAHATA K, Kanda M, Kamekura R, Sugawara M, et al
    Abnormal [(18)F]fluorodeoxyglucose accumulation to tori tubarius in IgG4-related disease.
    Ann Nucl Med. 2022;36:200-207.
    PubMed     Abstract available

    January 2022
    Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy.
    Ann Nucl Med. 2022 Jan 30. pii: 10.1007/s12149-021-01712.

  67. SATOH Y, Imokawa T, Fujioka T, Mori M, et al
    Deep learning for image classification in dedicated breast positron emission tomography (dbPET).
    Ann Nucl Med. 2022 Jan 27. pii: 10.1007/s12149-022-01719.
    PubMed     Abstract available

  68. SHI A, Wang J, Wang Y, Guo G, et al
    Predictive value of multiple metabolic and heterogeneity parameters of (18)F-FDG PET/CT for EGFR mutations in non-small cell lung cancer.
    Ann Nucl Med. 2022 Jan 27. pii: 10.1007/s12149-022-01718.
    PubMed     Abstract available

  69. INOUE Y, Ohkubo Y, Nagahara K, Uehara A, et al
    Conversion from dose length product to effective dose for the CT component of whole-body PET/CT.
    Ann Nucl Med. 2022 Jan 24. pii: 10.1007/s12149-022-01720.
    PubMed     Abstract available

  70. OTANI T, Saga T, Ishimori T, Kidera E, et al
    Detection efficacy of PET/CT with (18)F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study.
    Ann Nucl Med. 2022 Jan 22. pii: 10.1007/s12149-021-01704.
    PubMed     Abstract available

  71. MATSUBARA K, Ibaraki M, Nemoto M, Watabe H, et al
    A review on AI in PET imaging.
    Ann Nucl Med. 2022 Jan 14. pii: 10.1007/s12149-021-01710.
    PubMed     Abstract available

  72. AKAMATSU G, Shimada N, Matsumoto K, Daisaki H, et al
    New standards for phantom image quality and SUV harmonization range for multicenter oncology PET studies.
    Ann Nucl Med. 2022 Jan 14. pii: 10.1007/s12149-021-01709.
    PubMed     Abstract available

  73. MCKAY MJ, Taubman KL, Lee S, Scott AM, et al
    Radiotherapy planning of lymphomas: role of metabolic imaging with PET/CT.
    Ann Nucl Med. 2022 Jan 14. pii: 10.1007/s12149-021-01703.
    PubMed     Abstract available

  74. HIRATA K, Sugimori H, Fujima N, Toyonaga T, et al
    Artificial intelligence for nuclear medicine in oncology.
    Ann Nucl Med. 2022 Jan 14. pii: 10.1007/s12149-021-01693.
    PubMed     Abstract available

  75. WATANABE S, Ueno T, Kimura Y, Mishina M, et al
    Correction to: Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [(123)I]FP-CIT SPECT images.
    Ann Nucl Med. 2022 Jan 6. pii: 10.1007/s12149-021-01714.

  76. AKSU A, Vural Topuz O, Yilmaz G, Capa Kaya G, et al
    Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses.
    Ann Nucl Med. 2022 Jan 6. pii: 10.1007/s12149-021-01705.
    PubMed     Abstract available

    December 2021
  77. KESSEL K, Seifert R, Weckesser M, Boegemann M, et al
    Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging.
    Ann Nucl Med. 2021 Dec 2. pii: 10.1007/s12149-021-01702.
    PubMed     Abstract available

  78. HASHIMOTO T, Kondo N, Hirata M, Temma T, et al
    Development of radioiodinated pyrimidinopyridone derivatives as targeted imaging probes of activated p38alpha for single photon emission computed tomography.
    Ann Nucl Med. 2021;35:1293-1304.
    PubMed     Abstract available

    November 2021
  79. KITAMURA Y, Baba S, Isoda T, Maruoka Y, et al
    Usefulness of semi-quantitative analysis in (123)I metaiodobenzylguanidine SPECT/CT for the differentiation of pheochromocytoma and cortical adenoma.
    Ann Nucl Med. 2021 Nov 26. pii: 10.1007/s12149-021-01690.
    PubMed     Abstract available

  80. MA X, Guo L, Zhang H, Han K, et al
    Predictive value of SPECT myocardial perfusion imaging in patients with unrevascularized coronary chronic total occlusion.
    Ann Nucl Med. 2021 Nov 10. pii: 10.1007/s12149-021-01692.
    PubMed     Abstract available

  81. ICHIKAWA H, Miyaji N, Onoguchi M, Shibutani T, et al
    Feasibility of ultra-high-speed acquisition in xSPECT bone algorithm: a phantom study with advanced bone SPECT-specific phantom.
    Ann Nucl Med. 2021 Nov 3. pii: 10.1007/s12149-021-01689.
    PubMed     Abstract available

  82. GUO H, Xu K, Duan G, Wen L, et al
    Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine.
    Ann Nucl Med. 2021 Nov 2. pii: 10.1007/s12149-021-01683.
    PubMed     Abstract available

    October 2021
  83. CHEN Y, Wang Z, Yin G, Sui C, et al
    Prediction of HER2 expression in breast cancer by combining PET/CT radiomic analysis and machine learning.
    Ann Nucl Med. 2021 Oct 30. pii: 10.1007/s12149-021-01688.
    PubMed     Abstract available

  84. OZKAN ZG, Has Simsek D, Kuyumcu S, Oflas M, et al
    Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up : FDG PET in recurrent colorectal CA.
    Ann Nucl Med. 2021 Oct 14. pii: 10.1007/s12149-021-01684.
    PubMed     Abstract available

  85. KAWAKUBO M, Nagao M, Kikuchi N, Yamamoto A, et al
    (13)N-ammonia positron emission tomography-derived left-ventricular strain in patients after heart transplantation validated using cardiovascular magnetic resonance feature tracking as reference.
    Ann Nucl Med. 2021 Oct 13. pii: 10.1007/s12149-021-01686.
    PubMed     Abstract available

  86. NAKAYA M, Kurokawa R, Kanemaru N, Sakamoto N, et al
    Physiological 2-deoxy-2-[fluorine-18] fluoro-D-glucose accumulation in the thenar eminence in adults: a single-center retrospective study.
    Ann Nucl Med. 2021;35:1167-1173.
    PubMed     Abstract available

  87. TARTAGLIONE G, Foschi N, Ragonese M, Recupero SM, et al
    A gravity-assisted approach to the management of urinary diversion: (99m)Tc-MAG3 diuresis renography with F + 10(sp) method.
    Ann Nucl Med. 2021;35:1127-1135.
    PubMed     Abstract available

    September 2021
  88. ONWANNA J, Chantadisai M, Tepmongkol S, Fahey F, et al
    Impact of reconstruction parameters on lesion detection and localization in joint ictal/inter-ictal SPECT reconstruction.
    Ann Nucl Med. 2021 Sep 24. pii: 10.1007/s12149-021-01680.
    PubMed     Abstract available

  89. IONESCU TM, Jalloul W, Stolniceanu CR, Iacob R, et al
    Transthyretin cardiac amyloidosis: a review of the nuclear imaging findings with emphasis on the radiotracers mechanisms.
    Ann Nucl Med. 2021;35:967-993.
    PubMed     Abstract available

    August 2021
  90. ELBOGA U, Sahin E, Kus T, Cayirli YB, et al
    Superiority of (68)Ga-FAPI PET/CT scan in detecting additional lesions compared to (18)FDG PET/CT scan in breast cancer.
    Ann Nucl Med. 2021 Aug 26. pii: 10.1007/s12149-021-01672.
    PubMed     Abstract available

  91. KOTANI T, Nishimura M, Tamaki N, Matsushima S, et al
    Comparison between dynamic whole-body FDG-PET and early-delayed imaging for the assessment of motion in focal uptake in colorectal area.
    Ann Nucl Med. 2021 Aug 23. pii: 10.1007/s12149-021-01671.
    PubMed     Abstract available

  92. ZHENG S, Lin R, Chen S, Zheng J, et al
    Characterization of the benign lesions with increased (68)Ga-FAPI-04 uptake in PET/CT.
    Ann Nucl Med. 2021 Aug 23. pii: 10.1007/s12149-021-01673.
    PubMed     Abstract available

  93. WAKABAYASHI T, Hirose Y, Miyake K, Arakawa Y, et al
    Determining the extent of tumor resection at surgical planning with (18)F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials.
    Ann Nucl Med. 2021 Aug 18. pii: 10.1007/s12149-021-01670.
    PubMed     Abstract available

  94. UCHIYAMA Y, Hirata K, Watanabe S, Okamoto S, et al
    Development and validation of a prediction model based on the organ-based metabolic tumor volume on FDG-PET in patients with differentiated thyroid carcinoma.
    Ann Nucl Med. 2021 Aug 11. pii: 10.1007/s12149-021-01664.
    PubMed     Abstract available

  95. KITA A, Okazawa H, Sugimoto K, Kaido R, et al
    Acquisition count dependence of the specific binding ratio in (123)I-FP-CIT SPECT.
    Ann Nucl Med. 2021 Aug 10. pii: 10.1007/s12149-021-01668.
    PubMed     Abstract available

  96. ITO K, Kitajima K, Toriihara A, Ishibashi M, et al
    (18)F-FDG PET/CT for monitoring anti-PD-1 therapy in patients with non-small cell lung cancer using SUV harmonization of results obtained with various types of PET/CT scanners used at different centers.
    Ann Nucl Med. 2021 Aug 9. pii: 10.1007/s12149-021-01667.
    PubMed     Abstract available

  97. TOYOHARA J, Sakata M, Ishibashi K, Mossel P, et al
    First clinical assessment of [(18)F]MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood-brain barrier.
    Ann Nucl Med. 2021 Aug 8. pii: 10.1007/s12149-021-01666.
    PubMed     Abstract available

  98. WATANABE S, Ueno T, Kimura Y, Mishina M, et al
    Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [(123)I]FP-CIT SPECT images.
    Ann Nucl Med. 2021 Aug 4. pii: 10.1007/s12149-021-01661.
    PubMed     Abstract available

    July 2021
  99. BORGHETTI P, Toraci C, Imbrescia J, Volpi G, et al
    The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy.
    Ann Nucl Med. 2021 Jul 28. pii: 10.1007/s12149-021-01662.

  100. JO KH, Kim S, Hwang SH, Jeong YH, et al
    Characteristics of surgically transposed ovaries on (18)F-FDG PET/CT among patients with cancer.
    Ann Nucl Med. 2021 Jul 26. pii: 10.1007/s12149-021-01645.
    PubMed     Abstract available

  101. ACUNA HERNANDEZ M, Sanchez Orduz L, Cancino Ramos U, Vallejo Armenta P, et al
    Is there a consensus between clinical practice guidelines for conventional and molecular nuclear medicine studies in parathyroid pathology?
    Ann Nucl Med. 2021 Jul 24. pii: 10.1007/s12149-021-01658.
    PubMed     Abstract available

  102. SAGARA H, Inoue K, Yaku H, Ohsawa A, et al
    Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan.
    Ann Nucl Med. 2021 Jul 21. pii: 10.1007/s12149-021-01656.
    PubMed     Abstract available

  103. GALIUTO L, Leccisotti L, Locorotondo G, Porto I, et al
    Coronary plaque instability assessed by positron emission tomography and optical coherence tomography.
    Ann Nucl Med. 2021 Jul 17. pii: 10.1007/s12149-021-01651.
    PubMed     Abstract available

  104. GREGG S, Keramida G, Peters AM
    Measuring myocardial blood flow with (82)rubidium using Gjedde-Patlak-Rutland graphical analysis.
    Ann Nucl Med. 2021;35:777-784.
    PubMed     Abstract available

  105. SEKIKAWA Y, Funada K, Akamatsu G, Himuro K, et al
    Monte Carlo simulation of the acquisition conditions for (177)Lu molecular imaging of hepatic tumors.
    Ann Nucl Med. 2021;35:823-833.
    PubMed     Abstract available

  106. MORLAND D, Zizi G, Godard F, Gauchy AC, et al
    18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphoma.
    Ann Nucl Med. 2021;35:785-793.
    PubMed     Abstract available

  107. KOBAYASHI Y, Okui T, Tsujimoto M, Ikeda H, et al
    Effect of morphological findings in computed tomography on the quantitative values in single-photon emission computed tomography for patients with antiresorptive agent-related osteonecrosis of the jaw: a cross-sectional study.
    Ann Nucl Med. 2021;35:853-860.
    PubMed     Abstract available

  108. WATABE T, Hosono M, Kinuya S, Yamada T, et al
    Manual on the proper use of sodium astatide ([(211)At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition).
    Ann Nucl Med. 2021;35:753-766.
    PubMed     Abstract available

  109. MA G, Gu B, Hu J, Kong L, et al
    Pretreatment (18)F-FDG uptake heterogeneity can predict treatment outcome of carbon ion radiotherapy in patients with locally recurrent nasopharyngeal carcinoma.
    Ann Nucl Med. 2021;35:834-842.
    PubMed     Abstract available

    June 2021
  110. KUYUMCU S, Isik EG, Tiryaki TO, Has-Simsek D, et al
    Prognostic significance of (68)Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to (18)F-FDG PET/CT and laboratory results.
    Ann Nucl Med. 2021 Jun 29. pii: 10.1007/s12149-021-01652.
    PubMed     Abstract available

  111. FASSBIND S, Ferraro DA, Stelmes JJ, Fankhauser CD, et al
    (68)Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer.
    Ann Nucl Med. 2021 Jun 29. pii: 10.1007/s12149-021-01646.
    PubMed     Abstract available

  112. OZTURK BC, Atahan E, Gencer A, Harbiyeli DO, et al
    Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.
    Ann Nucl Med. 2021 Jun 25. pii: 10.1007/s12149-021-01647.
    PubMed     Abstract available

  113. KARLS S, Gold R, Kravets S, Wang Y, et al
    Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms.
    Ann Nucl Med. 2021 Jun 19. pii: 10.1007/s12149-021-01642.
    PubMed     Abstract available

  114. KAUSHIK P, Patel C, Gulati GS, Seth S, et al
    Comparison of (68)Ga-DOTANOC PET/CT with cardiac MRI in patients with clinical suspicion of cardiac sarcoidosis.
    Ann Nucl Med. 2021 Jun 14. pii: 10.1007/s12149-021-01641.
    PubMed     Abstract available

  115. LEE SW, Jeong SY, Kim K, Kim SJ, et al
    Direct comparison of F-18 FDG PET/CT and MRI to predict pathologic response to neoadjuvant treatment in locally advanced rectal cancer: a meta-analysis.
    Ann Nucl Med. 2021 Jun 10. pii: 10.1007/s12149-021-01639.
    PubMed     Abstract available

  116. KARAHAN SEN NP, Aksu A, Capa Kaya G
    A different overview of staging PET/CT images in patients with esophageal cancer: the role of textural analysis with machine learning methods.
    Ann Nucl Med. 2021 Jun 9. pii: 10.1007/s12149-021-01638.
    PubMed     Abstract available

  117. IKOMA Y, Takuwa H, Nishino A, Maeda J, et al
    Measurement of changes in endogenous serotonin level by positron emission tomography with [(18)F]altanserin.
    Ann Nucl Med. 2021 Jun 8. pii: 10.1007/s12149-021-01633.
    PubMed     Abstract available

  118. LI Y, Li Y, Huang Y, Wu X, et al
    Usefulness of (18)F-FDG PET/CT in treatment-naive patients with thymic squamous cell carcinoma.
    Ann Nucl Med. 2021 Jun 8. pii: 10.1007/s12149-021-01640.
    PubMed     Abstract available

  119. LUO R, Wang L, Ye F, Wang YR, et al
    [(18)F]FEDAC translocator protein positron emission tomography-computed tomography for early detection of mitochondrial dysfunction secondary to myocardial ischemia.
    Ann Nucl Med. 2021 Jun 3. pii: 10.1007/s12149-021-01630.
    PubMed     Abstract available

  120. NI YC, Tseng FP, Pai MC, Hsiao IT, et al
    Detection of Alzheimer's disease using ECD SPECT images by transfer learning from FDG PET.
    Ann Nucl Med. 2021 Jun 2. pii: 10.1007/s12149-021-01626.
    PubMed     Abstract available

  121. FUKUNAGA T, Sanui K, Kadokami T, Sasaki M, et al
    Influences of radionuclides on left ventricular phase analysis of gated myocardial perfusion single-photon emission computed tomography images in ischemic heart disease.
    Ann Nucl Med. 2021;35:735-743.
    PubMed     Abstract available

  122. QIU ZL, Saito S, Kayano D, Wakabayashi H, et al
    Comparison of the detecting capability between (123)I-mIBG and post-therapeutic (131)I-mIBG scintigraphy for curie scoring in patients with neuroblastoma after chemotherapy.
    Ann Nucl Med. 2021;35:649-661.
    PubMed     Abstract available

  123. KAPADIA A, Desai P, Dmytriw A, Maralani P, et al
    In vivo detection of beta-amyloid at the nasal cavity and other skull-base sites: a retrospective evaluation of ADNI1/GO.
    Ann Nucl Med. 2021;35:728-734.
    PubMed     Abstract available

    May 2021
  124. EVANGELISTA L, Zucchetta P, Moletta L, Serafini S, et al
    The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review.
    Ann Nucl Med. 2021 May 28. pii: 10.1007/s12149-021-01629.
    PubMed     Abstract available

  125. OTANI T, Otsuka H, Matsushita K, Otomi Y, et al
    Effect of different examination conditions on image quality and quantitative value of amyloid positron emission tomography using (18)F-flutemetamol.
    Ann Nucl Med. 2021 May 27. pii: 10.1007/s12149-021-01634.
    PubMed     Abstract available

  126. ICHIKAWA H, Kawakami K, Onoguchi M, Shibutani T, et al
    Automatic quantification package (Hone Graph) for phantom-based image quality assessment in bone SPECT: computerized automatic classification of detectability.
    Ann Nucl Med. 2021 May 24. pii: 10.1007/s12149-021-01631.
    PubMed     Abstract available

  127. TERESINSKA A, Wozniak O, Maciag A, Wnuk J, et al
    Quality and utility of [(123)I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillator.
    Ann Nucl Med. 2021 May 23. pii: 10.1007/s12149-021-01628.
    PubMed     Abstract available

  128. HUNG GU, Zou J, He Z, Zhang X, et al
    Left-ventricular dyssynchrony in viable myocardium by myocardial perfusion SPECT is predictive of mechanical response to CRT.
    Ann Nucl Med. 2021 May 21. pii: 10.1007/s12149-021-01632.
    PubMed     Abstract available

  129. KIM M, Gu W, Nakajima T, Higuchi T, et al
    Texture analysis of [(18)F]-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the treatment response of postoperative recurrent or metastatic oral squamous cell carcinoma treated with cetuximab.
    Ann Nucl Med. 2021 May 20. pii: 10.1007/s12149-021-01623.
    PubMed     Abstract available

  130. CHIMURA M, Ohtani T, Sera F, Nakamoto K, et al
    Focal severe decrease in myocardial technetium-99 m sestamibi uptake indicates ventricular irreversibility in patients with dilated cardiomyopathy.
    Ann Nucl Med. 2021 May 18. pii: 10.1007/s12149-021-01625.
    PubMed     Abstract available

  131. ASA S, Sonmezoglu K, Uslu-Besli L, Sahin OE, et al
    Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT.
    Ann Nucl Med. 2021 May 15. pii: 10.1007/s12149-021-01627.
    PubMed     Abstract available

  132. HOTTA M, Minamimoto R, Gohda Y, Miwa K, et al
    Prognostic value of (18)F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery.
    Ann Nucl Med. 2021 May 4. pii: 10.1007/s12149-021-01622.
    PubMed     Abstract available

  133. KOMEK H, Can C, Guzel Y, Oruc Z, et al
    (68)Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the (18)F-FDG PET/CT.
    Ann Nucl Med. 2021 May 2. pii: 10.1007/s12149-021-01616.
    PubMed     Abstract available

  134. LEE CH, Lim I, Woo SK, Kim W, et al
    Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of (225)Ac-DOTA-rituximab using (64)Cu-DOTA-rituximab.
    Ann Nucl Med. 2021;35:639-647.
    PubMed     Abstract available

  135. JUWEID ME, Alhouri A, Baniissa B, Rimawi D, et al
    Transient ischemic dilatation with adenosine (99m)Tc-sestamibi stress: prognostic significance in patients with normal myocardial perfusion.
    Ann Nucl Med. 2021;35:569-579.
    PubMed     Abstract available

  136. HUANG HL, Ngam PI, Tan KM, Ng DCE, et al
    The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphoma.
    Ann Nucl Med. 2021;35:557-568.
    PubMed     Abstract available

  137. TUNCEL M, Telli T, Tuncali MC, Karabulut E, et al
    Predictive factors of tumor sink effect: Insights from (177)Lu-Prostate-specific membrane antigen therapy.
    Ann Nucl Med. 2021;35:529-539.
    PubMed     Abstract available

    April 2021
  138. KURISU S, Nitta K, Watanabe N, Ikenaga H, et al
    Associations of frontal QRS-T angle with left ventricular volume and function derived from ECG-gated SPECT in patients with advanced chronic kidney disease.
    Ann Nucl Med. 2021 Apr 18. pii: 10.1007/s12149-021-01596.
    PubMed     Abstract available

  139. HOU Y, Guo K, Fan X, Shang K, et al
    Crossed cerebellar diaschisis: risk factors and prognostic value in focal cortical dysplasia by (18)F-FDG PET/CT.
    Ann Nucl Med. 2021 Apr 11. pii: 10.1007/s12149-021-01613.
    PubMed     Abstract available

  140. HASHIMOTO F, Ito M, Ote K, Isobe T, et al
    Deep learning-based attenuation correction for brain PET with various radiotracers.
    Ann Nucl Med. 2021 Apr 3. pii: 10.1007/s12149-021-01611.
    PubMed     Abstract available

  141. CHOI YJ, Jo K, Hwang SH, Jeong Y, et al
    Association between PD-L1 expression and (18)F-FDG uptake in ovarian cancer.
    Ann Nucl Med. 2021;35:415-420.
    PubMed     Abstract available

  142. BANDO R, Otsuka H, Otani T, Matsuda N, et al
    A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography.
    Ann Nucl Med. 2021;35:504-513.
    PubMed     Abstract available

  143. RADNIA A, Abdollahzadeh H, Teimourian B, Farahani MH, et al
    Development and characterization of an all-in-one gamma probe with auto-peak detection for sentinel lymph node biopsy based on NEMA NU3-2004 standard.
    Ann Nucl Med. 2021;35:438-446.
    PubMed     Abstract available

    March 2021
  144. SHAO F, Zhao X, Toyama H, Ichihara T, et al
    Semi-quantitative assessment optimized the grading of pulmonary aspiration on salivagram in children.
    Ann Nucl Med. 2021;35:321-327.
    PubMed     Abstract available

  145. DOTINGA M, van Dijk JD, Vendel BN, Slump CH, et al
    Clinical value of machine learning-based interpretation of I-123 FP-CIT scans to detect Parkinson's disease: a two-center study.
    Ann Nucl Med. 2021;35:378-385.
    PubMed     Abstract available

    February 2021
  146. SAKATANI T, Nakajima K, Fujita H, Nishimura T, et al
    Cardiovascular event risk estimated after coronary revascularization and optimal medical therapy: J-ACCESS4 prognostic study.
    Ann Nucl Med. 2021;35:241-252.
    PubMed     Abstract available

  147. KANG JY, Lee MY, Kim YH
    Associations of physiologic myocardial (18)F-FDG uptake with fasting duration, HbA1c, and regular exercise.
    Ann Nucl Med. 2021;35:195-202.
    PubMed     Abstract available

  148. KONISHI K, Ishiba R, Ikenohira T, Asao T, et al
    The relationship between the quantitative evaluation of thyroid bed uptake and the disappearance of accumulation in adjuvant radioactive iodine therapy for differentiated thyroid cancer.
    Ann Nucl Med. 2021;35:159-166.
    PubMed     Abstract available

    January 2021
  149. PARGHANE RV, Talole S, Basu S
    (131)I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with (177)Lu-DOTATATE peptide receptor radionuclide therapy.
    Ann Nucl Med. 2021;35:92-101.
    PubMed     Abstract available

  150. SHIN S, Nam HY, Lee MJ, Pak K, et al
    Effect of sex on aging-related decline of dopamine transporter in healthy subjects.
    Ann Nucl Med. 2021;35:76-82.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.